Open Accessibility Menu

Monoclonal Antibody Infusion & COVID-19 Vaccines

Monoclonal Antibody Infusion

Monoclonal antibody therapy helps prevent hospitalization or worsening of symptoms in patients with COVID-19.

Infusion Criteria-Who is eligible? Must meet all 5 requirements.
  • Patient has laboratory confirmed COVID-19 and within 7 days of symptom onset (mild to moderate symptoms present).
    *Patients meeting immunocompromised status may be eligible if symptom onset within the past 10 days
  • Patient is 18 years of age or older and weighing at list 40 kg (88lbs)
  • Mild to Moderate symptoms present (fevers, cough, sore throat, malaise, headache, muscle pain, gastrointestinal symptoms shortness of breath with exertion).
    NOTE: Not recommended/authorized for asymptomatic disease.
  • Patient must meet the criteria point score of >5 to qualify for treatment during periods for medication shortage.
  • Patient has as at least one risk factor* associated with progressing to severe COVID-19 and/or hospitalization or death:
Risk factors associated with progressing to severe COVID-19 and/or hospitalization
  • Have a body mass index (BMI) >35 and age >40
  • Have chronic kidney disease
  • Diabetes
  • Immunosuppressive disease or immunosuppressive treatment
  • Are >65 years of age
  • Pregnancy
  • Cardiovascular disease (including congenital heart disease) or hypertension
  • Patient meets “high-risk” criteria per EUA Health Care Provider Fact sheets. Please note that BMI >25 but <30 will not be eligible if fully vaccinated and under age 40.
  • Chronic lung diseases (for example, chronic obstructive pulmonary disease, asthma [moderate-to-severe], interstitial lung disease, cystic fibrosis and pulmonary hypertension)
  • Sickle cell disease
  • Neurodevelopmental disorders (for example, cerebral palsy) or other conditions that confer medical complexity (for example, genetic or metabolic syndromes and severe congenital anomalies)
  • Having a medical-related technological dependence (e.g., tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID 19)
  • Other
If you are unsure, consult with us at the ECRMC Antibody Infusion Center. The ECRMC Antibody Infusion Center is located in the Emergency Department at ECRMC (1415 Ross Avenue, El Centro, CA).

The Infusion Center is open 24 hours a day, 7 days a week.
To learn more click here.